Módulo 1
Introdução
Propriedades
  Farmacocinética
Tratamento
Comunitárias
Antimicrobianos - Base Teóricas e Uso Clínico

V. Bibliografia consultada

Tratamento das infecções | Profilaxia das infecções

Tratamento das infecções

1. Amato Neto V, Nicodemo AC, Lopes HV. Antibióticos na prática clínica. 6ª ed. São Paulo: Sarvier Editora; 2007.

2. Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centers: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother. 2003; 52:140-1. Disponível em: http://jac.oxfordjournals.org/cgi/reprint/52/1/140.

3. Bartlett JG, Auwaerter PG and Pham PA, editors. The ABX Guide – Diagnosis and treatment of infectious diseases. 1th ed. New Jersey: Thomson; 2005. Disponível em: http://www.hopkins-abxguide.org

4. Bartlett JG, Dowell SF, Mandell LA, File TM Jr., Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000; 31:347-82.

5. Barton, L, Hodgman, JE, Pavlova, Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999; 103:446. Disponível em: http://pediatrics.aappublications.org/cgi/reprint/103/2/446.

6. Boletim Epidemiológico Paulista. 2005. Ano 2, Número 17, p 15. Disponível em: ftp://ftp.cve.saude.sp.gov.br/doc_tec/outros/bol_bepa1705.pdf

7. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003; 290(19):2588-98. Disponível em:  http://jama.ama-assn.org/cgi/reprint/290/19/2588

8. Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals. Med Mycol. 2003; 41:235-39.

9. Cunha CA, Sader HS, Nicodemo AC and Brazilian Society for Infectious Diseases Practice Guideline Commitee. Antimicrobial Therapy for Community-Acquired Pneumonia in Adults. Braz J Infect Dis.  2002; 6(2): 82-87.

10. Damas P, Garweg C, Monchi M, Nys M, Canivet JL, Ledoux D, Preiser JC. Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN 31976779]. Crit Care. 2006; 10(2):R52. Disponível em: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1550875&blobtype=pdf

11. Diretrizes brasileiras para tratamento das pneumonias adquiridas no hospital e das associadas à ventilação mecânica – 2007 e Diretrizes brasileiras em pneumonia adquirida na comunidade em pediatria – 2007. J Bras. Pneumol, 33 suppl 1: S1-S50. Disponível em: http://www.jornaldepneumologia.com.br/portugues/suplementos_caps.asp?id=44

12. Drusano G. Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telitromycin. Clin Microbiol Infect. 2001; 7(suppl 3): 24-29.

13. Edwards MS, Nizet V, Baker CJ. Group B Streptococcal Infections. In: Remington JS, Klein JO. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia: Elsevier Saunders; 2006. p.403. 

14. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med. 1999; 27:1066-72.

15. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR,  et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. 1998; 17(7):593-9. 

16. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997; 336(4):243-50.

17. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother. 1997; 39:677-686. Disponível em: http://jac.oxfordjournals.org/cgi/reprint/39/6/677

18. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999; 29(2):245-252.

19. Gales AC, Sader HS, Jones RN, and The SENTRY study group (Latin America). Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000). Diag Microbiol Infect Dis. 2002; 44: 289-299.

20. Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy. 37a ed. Dallas: Editorial Office; 2007.

21. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am J Respir Crit Care Med. 2005; 171: 88–416. Disponível em: http://ajrccm.atsjournals.org/cgi/reprint/171/4/388

22. Hair PI and Keam SJ. Daptomicyn - A Review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Drugs. 2007; 67(10): 1483-1512.

23. Lopes HV, Tavares W. Associação Médica Brasileira – Infecção do trato urinário alto de origem comunitária e hospitalar – tratamento. Projeto Diretrizes, 2004.  Disponível em: http://www.projetodiretrizes.org.br/projeto_diretrizes/064.pdf       

24. Maestre JR. Infecciones bacterianas mixtas de la cavidad oral. Enferm Infect Microbiol Clin 2002; 20:98-101.

25. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C; Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect (Larchmt). 2002; 3:175-233. Disponível em: http://www.escmid.org/Files/Surgical_Infection_Executive.pdf

26. Medeiros EAS, Machado A, Ferraz AAB, Ferraz E, Arruda E, Nobre J,  et al. Associação Médica Brasileira. Projeto Diretrizes. Prevenção de Infecção Hospitalar. São Paulo, 2001. Disponível em:  http://www.projetodiretrizes.org.br/projeto_diretrizes/065.pdf

27. Mendes RE, Reis AO, Gales AC, Jones RN, Sader HS. Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000). Braz J Infect Dis. 2003; 7:282-89.

28. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE, and Infectious Diseases Society of America, American College of Critical Care Medicine, Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001; 32:1249-1272.

29. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM, Infectious Diseases Society of America,  American Society of Nephrology, and American Geriatric Society. Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults. Clin Infect Dis. 2005; 40(5):643-654.

30. Pádua JM, Rocha LB, Lia RCC, Pietro RCLR, Kashima S, Almeida AMF. Disseminação de infecção purulenta envolvendo segundo e terceiro molares inferiores – relato de caso clínico. BCI. 2000; 7(25):30-2.

31. Perri de Carvalho AC, Perri de Carvalho OS, Andrade ED, Passeri LA. Tratamento dos abscessos de origem dental. Odontologia Moderna. 1988; 15(10):34-9.

32. Pessoa-Silva CL, Richtmann R, Calil R, Santos RM, et al. Health-associated infections among neonates in Brazil. Infect Control Hosp Epidemiol. 2004; 25(9): 772-77.

33. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis. 2005; 40(12):1792-98.

34. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007; 7:645-57.

35. Renato Grinbaum. Tratamento das infecções hospitalares: uma abordagem prática. 1a ed. São Paulo: Ed. Planmark; 2005.

36. Sader HS, Gales AC, Granacher TD, Pfaller MA, Jones RN, and The SENTRY study group (Latin America). Prevalence of antimicrobial resistence among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98). Braz J Infect Dis. 2000; 4(5)245-54.

37. Sader HS, Gales AC, Pfaller MA, Mendes RE, Zoccoli C, Barth A, Jones RN. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program. Braz J Infect Dis. 2001; 5(4):200-14. Disponível em: http://www.scielo.br/pdf/bjid/v5n4/v5n4a06.pdf

38. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis. 2004; 4:519-27.

39. Salomão R e Pignatari ACC. Guia de Medicina Ambulatorial e Hospitalar UNIFESP/Escola Paulista de Medicina. Infectologia. 1ª ed. São Paulo: Ed. Manole; 2004.

40. Silva HL, Strabelli TM, Cunha ER, Neres SF,Camargo LF,Uip DE. Nosocomial coagulase-negative Staphylococci bacteremia: five year prospective data collection. Braz J Infect Dis. 2000; 4:271-74.

41. Sociedade Paulista de Infectologia. Diretrizes sobre pneumonia associada a ventilação mecânica, 2006. Disponível em:   http://www.infectologia.org.br/anexos/Consenso%20SPI_Diretrizes%20sobre%20PAV.pdf

42. Speelberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld M et al. The epidemic of antimicrobial-resistant infections: a call to action for the medical community from the infectious diseases society of America. Clin Infect Dis. 2008; 46:155-65. Disponível em: http://www.journals.uchicago.edu/doi/pdf/10.1086/524891

43. Topazian RG, Goldberg MH, Hupp JR. Infecções orais e maxilofaciais. 4ª ed. Trad: Kátia Cristina Beltrame e Fábio Luiz Andretti. São Paulo: Santos; 2006.

44. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice Guidelines for the Management of Bacterial Meningitis Clin Infect Dis. 2004; 39(9):1267–84.

45. van de Beek D, de Gans J. Dexamethasone in adults with bacterial meningitis. Drugs. 2006; 66(4): 415-27.

46. Zavascki AP, Cruz RP, Goldani LZ. High rate of antimicrobial resistance in Pseudomonas aeruginosa at a tertiary-care teaching hospital in southern Brazil. Infect Control Hosp Epidemiol. 2004; 25:805-7.

 


Profilaxia das Infecções

1. American Dental Association; American Academy of Orthopaedic Surgeons. Antibiotic prophylaxia for dental patients with total joint replacements. J Am Dent Assoc 1997; 128 (7):1004-8. Disponível em: http://www.ada.org/prof/resources/pubs/jada/reports/report_prophy_statement.pdf.

2. Bergamini TM, Polk HC. Pharmacodynamics of antibiotic penetration of tissue and surgical prophylaxis. Surg Gynecol Obstet. 1989;168(3):283-9.

3. Burke JF. The effective period odd preventive antibiotic action in experimental incision and dermal lesions. Surgery. 1961;50(2):161-8.

4. Dellinger EP, Gross PA, Barrett TL, Krause PJ, Martone WJ, McGowan JE, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis. 1994;18(3):422-7.

5. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty five open fractures of long bones: retrospective and prospective analysis. J Bone Joint Surg [Am]. 1976; 58: 453-458. Disponível em: http://www.ejbjs.org/cgi/reprint/58/4/453.

6. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916-21. Disponível em: http://circ.ahajournals.org/cgi/reprint/101/25/2916.

7. Niederhauser U, Vogt M, Vogt P, Genoni M, Kunzli A, Turina MI. Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective? J Thorac Cardiovasc Surg. 1997;114(2):162-8.

8. Tong D, Rothwell B. Antibiotic proprylaxis in dentistry: A review and practice recomendations. . J Am Dent Assoc. 2000; 131 (3): 366-74. Disponível em: http://jada.ada.org/cgi/reprint/131/3/366.

9. Whitener CJ and Hamory BH. Nosocomial infections in dental, oral and macillofacial surgery. *In*: C. Mayhall CG. Hospital epidemiology and infection control. Second edition. Philadelphia: Lippincott Williams & Wikins; 1999. p. 719-728.

10. Wilson W. Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007; 9 (116):1736-1754. Dispon ível em: http://circ.ahajournals.org/cgi/reprint/116/15/1736.pdf

11. Zelenitsky SA, Silverman RE, Duckworth H, Harding GK. A prospective, randomized, double-blind study of single high dose versus multiple standard dose gentamicin both in combination with metronidazole for colorectal surgical prophylaxis. J Hosp Infect. 2000;46(2):135-40.

« voltar 1  
                                      ATMracional, 2008